Morning Alert: Amicus Therapeutics (NASDAQ:FOLD), EMC (NYSE:EMC), Rubicon Technology (NASDAQ:RBCN), Quest Rare Minerals Ltd. (NYSEMKT:QRM), Vera Bradley, Inc. (NASDAQ:VRA)

Amicus Therapeutics, Inc. (NASDAQ:FOLD) currently has a Zacks Rank #2 (Buy). Amicus Therapeutics, Inc. (NASDAQ:FOLD) belongs to Healthcare sector. Its weekly performance is 34.38%. On last trading day company shares ended up $7.27. Amicus Therapeutics, Inc. (NASDAQ:FOLD) distance from 50-day simple moving average (SMA50) is 76.12%. EMC (NYSE:EMC) declared a quarterly dividend on Friday, August 1st. Investors of record on Wednesday, October 1st will be given … Continue reading Morning Alert: Amicus Therapeutics (NASDAQ:FOLD), EMC (NYSE:EMC), Rubicon Technology (NASDAQ:RBCN), Quest Rare Minerals Ltd. (NYSEMKT:QRM), Vera Bradley, Inc. (NASDAQ:VRA)

Trader’s Watch List: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Chesapeake Energy Corporation (NYSE:CHK), Envivio, Inc. (NASDAQ:ENVI), Mannatech, Incorporated (NASDAQ:MTEX), Endocyte, Inc. (NASDAQ:ECYT)

Amicus Therapeutics (NASDAQ:FOLD) COO Bradley L. Campbell unloaded 18,750 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $5.40, for a total transaction of $101,250.00. Following the completion of the transaction, the chief operating officer now directly owns 200,000 shares in the company, valued at approximately $1,080,000. Amicus Therapeutics, Inc. (NASDAQ:FOLD) … Continue reading Trader’s Watch List: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Chesapeake Energy Corporation (NYSE:CHK), Envivio, Inc. (NASDAQ:ENVI), Mannatech, Incorporated (NASDAQ:MTEX), Endocyte, Inc. (NASDAQ:ECYT)

Top Gainers: USEC Inc. (NYSE:USU), Voxeljet (NYSE:VJET), Arista Networks Inc (NYSE:ANET), Amicus Therapeutics (NASDAQ:FOLD), Everyware Global (NASDAQ:EVRY)

USEC Inc. (NYSE:USU) closed up 143.89% today after news of its 8-K filing with the Securities and Exchange Commission (SEC) regarding new funding, of $2.5 million, from the US Department of Energy (DOE). The funding comes following an amendment to an agreement with a research lab operator for further research on American Centrifuge technology. USEC Inc. (NYSE:USU) stock performance was 143.89% in last session and … Continue reading Top Gainers: USEC Inc. (NYSE:USU), Voxeljet (NYSE:VJET), Arista Networks Inc (NYSE:ANET), Amicus Therapeutics (NASDAQ:FOLD), Everyware Global (NASDAQ:EVRY)

Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)

MannKind Corporation (NASDAQ:MNKD) VP David Thomson sold 30,000 shares of the stock on the open market in a transaction that occurred on Thursday, June 26th. The shares were sold at an average price of $10.51, for a total transaction of $315,300.00. Following the transaction, the vice president now directly owns 102,286 shares in the company, valued at approximately $1,075,026. MannKind Corporation (NASDAQ:MNKD) stock performance was … Continue reading Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)

Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)

MannKind Corporation (NASDAQ:MNKD) VP David Thomson sold 30,000 shares of the stock on the open market in a transaction that occurred on Thursday, June 26th. The shares were sold at an average price of $10.51, for a total transaction of $315,300.00. Following the transaction, the vice president now directly owns 102,286 shares in the company, valued at approximately $1,075,026. MannKind Corporation (NASDAQ:MNKD) stock performance was … Continue reading Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)